Phase II Rx By HoltraCeuticals Overview & Drug Interactions
Check For Interactions With Phase II Rx
Supplement: Phase II Rx by HoltraCeuticals
Phase II Rx Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Broccoli seed extract
| Ingredient Group | Broccoli |
|---|---|
| Category | botanical |
-
Providing 30 mg Sulforaphane Glucosinolate
Ingredient Group Glucoraphanin Category non-nutrient/non-botanical
Drugs that interact with Phase II Rx by HoltraCeuticals
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
1 Capsule(s)
|
| Maximum serving Sizes: |
1 Capsule(s)
|
| Servings per container | 120 |
| UPC/BARCODE | 871149006280 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Broccoli seed extract |
230 mg
|
Broccoli |
--
|
| Providing 30 mg Sulforaphane Glucosinolate |
30 mg
|
Glucoraphanin |
|
| Other Ingredients: |
HPMC
Microcrystalline Cellulose
Stearic Acid
Silicon Dioxide
Magnesium Stearate
|
|---|
Label Statments:
| Suggested/Recommended/Usage/Directions |
- Directions: Take one capsule daily or as directed by your healthcare practitioner.
|
|---|---|
| Seals/Symbols |
- Vegetable CAPSULES
- sgs(TM)
- {recycle}
|
| Formula |
- Each Phase II Rx capsule contains 30 mg sulforaphane glucosinolate (SGS(TM)).
- Sulforaphane Gluconsinolate
|
| Precautions |
- CAUTION: Keep out of reach of children.
|
| Storage |
- STORAGE: Keep tightly closed in a cool, dry place.
|
| Formulation |
- DOES NOT CONTAIN: Wheat, gluten, corn protein, yeast, soy, diary products, artificial colors, sweeteners or preservatives.
|
| FDA Statement of Identity |
- Dietary Supplement
|
| General Statements |
- HOLTORF MEDICAL GROUP, INC.
CENTER FOR HORMONE IMBALANCE, HYPOTHYROIDISM AND FATIGUE
- This package is completely recyclable
|
| Brand IP Statement(s) |
- Produced under U.S. Patents 5,725,895; 5,968,505; 5,968,567; 6,277,122 and 6,242,018 licensed from Brassica Protection Products LLC; SGS is a trademark of Brassica Protection Products.
- Scientists identified SGS(TM) as a natural long-lasting antioxidant and detoxifier found in broccoli and broccoli sprouts. SGS(TM) contributes to the integrity of all cells, promoting health and well-being. Since its discovery, more than 200 publications from universities worldwide have underscored the significance of sulforaphane glucosinolate. SGS(TM) activates the body's natural detoxification and antioxidant enzymes, protecting cells from free radical damage.*
|
| FDA Disclaimer Statement |
- *This is a statement of nutritional support. This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
|
Brand Information
See all products by this brand
| Formulated by and manufactured for | |
|---|---|
| Name | Kent Holtorf, M.D., & the Holtorf Medical Group., Inc |
| City | Torrance |
| State | CA |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.